New Oral AntiCoagulant Use in REnal Disease and AF (NOACURE-AF) Where do we stand? An expert consensus view using the Delphi method
Main Author: | Ali Çoner |
---|---|
Format: | Article |
Language: | English |
Published: |
KARE Publishing
2021-10-01
|
Series: | Türk Kardiyoloji Derneği Arşivi |
Online Access: | https://archivestsc.com/jvi.aspx?un=TKDA-08300&volume=49&issue=7 |
Similar Items
-
New Oral AntiCoagulants Use in REnal Disease and AF (NOACURE-AF) Where do we stand?: An expert consensus view using the Delphi method
by: Mustafa Arıcı, et al.
Published: (2021-07-01) -
Sleep Apnoea and AF: Where Do We Stand? Practical Advice for Clinicians
by: Suneet Mittal, et al.
Published: (2021-10-01) -
2023 APHRS expert consensus statements on surgery for AF
by: Takashi Nitta MD, PhD, et al.
Published: (2023-12-01) -
Catheter Ablation of Persistent AF—Where are We Now?
by: Louisa O’Neill, et al.
Published: (2023-11-01) -
Ablative Management of Persistent Atrial Fibrillation (PeAF) with Posterior Wall Isolation (PWI): Where Do We Stand?
by: Omar Baqal, et al.
Published: (2023-06-01)